CoChat

Defective Leukocyte GM-CSF Receptor (CD116) Expression and Function in Inflammatory Bowel Disease

Open access
Goldstein, Jonathan I., Kominsky, Douglas J., Jacobson, Nicole, Bowers, Brittelle, Regalia, Kirsten, Austin, Gregory L., Yousefi, Melinda, Falta, Michael T., Fontenot, Andrew P., Gerich, Mark E., Golden–Mason, Lucy, Colgan, Sean P. · 2011 · Gastroenterology
Cited by 53

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background and Aims Inflammatory bowel disease (IBD) refers to two chronic inflammatory diseases of the intestine: ulcerative colitis and Crohn’s disease. IBD results from environmental factors (e.g. bacterial antigens) triggering a dysregulated immune response in genetically predisposed hosts. While the basis of IBD is incompletely understood, a number of recent studies have implicated defective innate immune responses in the pathogenesis of IBD. In this regard, there is much interest in therapies that activate innate immunity (e.g. recombinant GM-CSF). Methods In this study, we screened expression and function of circulating leukocyte GM-CSF receptor (CD116) mRNA and surface protein in 52 IBD patients and 52 healthy controls. Results Our results show that both granulocyte and monocyte CD116 levels, but not CD114 or IL-3Rα, were significantly repressed in IBD compared to control (p<0.001) and disease controls (irritable bowel syndrome, IBS, p<0.001; rheumatoid arthritis, RA, p<0.025). IBD-associated CD116 repression was more prominent in patients with ulcerative colitis compared to Crohn’s disease (p<0.05), was independent of disease activity (p>0.05) and was not influenced by current medications (p>0.05). Receiver operating characteristic (ROC) curve analysis revealed that leukocyte CD116 expression is a sensitive (85%) and specific (92%) biomarker for IBD. Moreover, granulocyte CD116-mediated function (phosphorylation of STAT3) paralleled decreased expression of CD116 in IBD granulocytes compared to control (p<0.001). Conclusion These studies identify repression of CD116 as a distinguishing feature of IBD and implicate an associated defect in innate immune responses toward GM-CSF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2011.03.060

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 53

Metadata

Authors
Goldstein, J. I., Kominsky, D. J., Jacobson, N., Bowers, B., Regalia, K., Austin, G. L., Yousefi, M., Falta, M. T., Fontenot, A. P., Gerich, M. E., Golden–Mason, L., & Colgan, S. P.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2011-07
Volume
141
Issue
1
Pages
208-216
ISSN
0016-5085 (ISSN-L)
OpenAlex
W1963826116
Cited by
53
References
4
FWCI
4.02
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defective Leukocyte GM-CSF Receptor (CD116) Expression and Function in Inflammatory Bowel Disease. https://app.cochat.ai/papers/10.1053/j.gastro.2011.03.060
The paper
Goldstein, J. I., Kominsky, D. J., Jacobson, N., Bowers, B., Regalia, K., Austin, G. L., Yousefi, M., Falta, M. T., Fontenot, A. P., Gerich, M. E., Golden–Mason, L., & Colgan, S. P. (2011). Defective Leukocyte GM-CSF Receptor (CD116) Expression and Function in Inflammatory Bowel Disease. Gastroenterology. https://doi.org/10.1053/j.gastro.2011.03.060

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.